Nephron-Sparing and Chemoablation in Upper Tract Urothelial Carcinoma

At the Society of Urologic Oncology Annual Meeting, Katie S. Murray, DO, NYU Grossman School of Medicine, and Christopher Wallis, MD, PhD, FRCSC, University of Toronto, discuss the nuances of chemoablation and renal preservation in upper tract urothelial carcinoma.

They highlight including optimal patient selection, size criteria, and how surgical ablation and chemoablation can fit together.

Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Oliver Sartor, MDRLT | December 4, 2023
Drs. Wallis and Sartor highlight issues with the control arm and considerations for treatment sequencing related to PSMAfore.
View More
Oliver Sartor, MDRLT | December 4, 2023
Dr. Sartor explains in detail the design and methodology, specific findings, nuances, and implications of the PSMAfore trial.
Christopher Wallis, MD, PhD, FRCSCSUO 2023 | December 1, 2023
Drs. Joyce and Wallis consider the impact of financial toxicity and containing costs for patients with GU malignancies.
Christopher Wallis, MD, PhD, FRCSCSUO 2023 | December 1, 2023
Drs. Pal and Wallis break down the role of the microbiome and response in patients with kidney cancer.

Video Insights

Clinical discussions with experts in the field

Network Websites